Skip to main content
. 2020 Nov 24;25:e925648-1–e925648-12. doi: 10.12659/AOT.925648

Table 2.

Comparison of clinical outcomes between non-RRT and RRT groups.

Variable Non-RRT (n=5) RRT (n=10) P value
Time of AKI, n (%) 1.000
 Pre-transplantation 4 (80.0) 9 (90.0)
 Post-transplantation 1 (20.0) 1 (10.0)
AKI stage, n (%) 0.661
 Stage I 2 (40.0) 2 (20.0)
 Stage II 1 (20.0) 4 (40.0)
 Stage III 2 (40.0) 4 (40.0)
ECMO during pre-transplant period, n (%) 4 (80.0) 9 (90.0) 1.000
Duration of ECMO (days), mean±SD 11.3±12.7 10.2±6.8 0.796
Urine volume during AKI period, ml/kg/hr, mean±SD 1.6±1.2 1.4±1.2 0.660
Interval from AKI to RRT start (days), mean±SD NA 1.3±1.3
Duration of RRT (days), median (IQR) NA 19.0 (5.0, 27.0)
Type of RRT, n (%)
 CRRT NA 9 (90.0)
 Intermittent HD NA 1 (10.0)
Recovery from AKI, n (%) 5 (100) 7 (70.0) 0.505
 Full recovery 4 (80.0) 4 (40.0) 0.576
 Partial recovery 1 (20.0) 3 (30.0) 0.576
Interval from AKI to renal function recovery after HT (days), median (IQR) 6.0 (3.5, 15.5) 22.0 (20.0, 64.0) 0.088

AKI – acute kidney injury; CRRT – continuous renal replacement therapy; ECMO – extracorporeal membrane oxygenation; HD – hemodialysis; HT – heart transplantation; IQR – interquartile range; RRT – renal replacement therapy; SD – standard deviation.